Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRBP
DateTimeSourceHeadlineSymbolCompany
11/12/20218:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
11/12/20218:05AMPR Newswire (US)Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
11/11/20218:05AMPR Newswire (US)Corbus Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
10/21/20219:30AMGlobeNewswire Inc.uniQure Announces the Appointment of Rachelle Jacques to its Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/28/20219:27AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/22/20217:53AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/12/20218:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/12/20218:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/22/20218:45AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/24/20218:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/24/20218:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of DermatomyositisNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/17/20214:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/17/20214:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/17/20214:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/17/20214:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/17/20214:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/17/20214:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/01/20211:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/01/20217:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/01/20217:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic DiseasesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/25/20218:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual CongressNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/19/20219:28AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/19/20219:20AMGlobeNewswire Inc.CORBUS PHARMACEUTICALS ANNOUNCES ADJOURNMENT OF ANNUAL MEETINGNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/13/20218:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/13/20218:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/11/20211:34PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/11/20218:05AMGlobeNewswire Inc.Corbus Pharmaceuticals to Present at Three Upcoming Investor ConferencesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/20/20218:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of System...NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/12/20216:02AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
04/06/20214:57PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRBP